CurrentRheuma coverage · page 46 of 48

Rheumatology (Oxford)

Briefs 1,801–1,840 of 1,905 CurrentRheuma has covered from this journal, newest publication first

Latest from Rheumatology (Oxford)

All coverage, newest first

Rheumatology (Oxford)23 Aug 2022
Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis
Diagnostic or prognostic studyVasculitis & PMR
Rheumatology (Oxford)23 Aug 2022
Predictive value of the adjusted Global Anti-Phospholipid Syndrome Score on clinical recurrence in APS patients: a longitudinal study
Cohort studyLupus & APS
Rheumatology (Oxford)22 Aug 2022
Prevalence of undiagnosed axial spondyloarthritis in inflammatory bowel disease patients with chronic back pain: secondary care cross-sectional study
Cross-sectional studySpondyloarthritis & PsA
Rheumatology (Oxford)19 Aug 2022
Survival in Swedish patients with systemic sclerosis: a nationwide population-based matched cohort study
Cohort studySystemic sclerosis
Rheumatology (Oxford)18 Aug 2022
Patient-individual tapering of DMARDs in rheumatoid arthritis patients in a real-world setting
Cohort studyRA
Rheumatology (Oxford)17 Aug 2022
Comparing Canadian paediatric rheumatology practice to the 2019 ACR Juvenile Idiopathic Arthritis guidelines: results from the CAPRI Registry
Cross-sectional studyPediatric
Rheumatology (Oxford)17 Aug 2022
Rituximab as maintenance therapy following remission induction in relapsing or refractory systemic lupus erythematosus
Cohort studyLupus & APS
Rheumatology (Oxford)16 Aug 2022
Association between popliteal artery wall thickness and structural progression in patients with symptomatic knee osteoarthritis
Cohort studyOsteoarthritis
Rheumatology (Oxford)16 Aug 2022
AOSD endotypes based on immune cell profiles: patient stratification with hierarchical clustering analysis
Cross-sectional studyAutoinflammatory & rare
Rheumatology (Oxford)12 Aug 2022
Antiphospholipid antibodies in patients with calcific aortic valve stenosis
Case-control studyLupus & APS
Rheumatology (Oxford)12 Aug 2022
Time-dependent changes in RPILD and mortality risk in anti-MDA5+ DM patients: a cohort study of 272 cases in China
Cohort studyMyositis
Rheumatology (Oxford)12 Aug 2022
Does expert opinion match the definition of lupus low disease activity state? Prospective analysis of 500 patients from a Spanish multicentre cohort
Cross-sectional studyLupus & APS
Rheumatology (Oxford)12 Aug 2022
Clinical and therapeutic diversity in adult chronic nonbacterial osteomyelitis (CNO) of the sternocostoclavicular region: a meta-analysis
Meta-analysisAutoinflammatory & rare
Rheumatology (Oxford)12 Aug 2022
Anti-FHL1 autoantibodies in juvenile myositis are associated with anti-Ro52 autoantibodies but not with severe disease features
Cross-sectional studyMyositis
Rheumatology (Oxford)12 Aug 2022
Urinary CD163 is a marker of active kidney disease in childhood-onset lupus nephritis
Diagnostic or prognostic studyLupus & APS
Rheumatology (Oxford)11 Aug 2022
Mobilization with reduced cyclophosphamide for autologous stem cell transplantation is feasible in patients with systemic sclerosis
Cohort studySystemic sclerosis
Rheumatology (Oxford)11 Aug 2022
Comparing MRI and conventional radiography for the detection of structural changes indicative of axial spondyloarthritis in the ASAS cohort
Diagnostic or prognostic studySpondyloarthritis & PsA
Rheumatology (Oxford)11 Aug 2022
The effect of group-based cognitive behavioural therapy for insomnia in patients with rheumatoid arthritis: a randomized controlled trial
Randomized controlled trialRA
Rheumatology (Oxford)11 Aug 2022
Sexual dysfunction in women with systemic autoimmune rheumatic disorders: a systematic review and meta-analysis
Meta-analysisAcross diseases
Rheumatology (Oxford)10 Aug 2022
Human dermal fibroblast-derived exosomes induce macrophage activation in systemic sclerosis
Mechanistic studySystemic sclerosis
Rheumatology (Oxford)10 Aug 2022
Serum biomarkers in prednisolone-treated hand osteoarthritis patients
Secondary analysisOsteoarthritis
Rheumatology (Oxford)10 Aug 2022
Low-dose rituximab is efficacious in refractory idiopathic inflammatory myopathies
Cohort studyMyositis
Rheumatology (Oxford)10 Aug 2022
Specific enterotype of gut microbiota predicted clinical effect of methotrexate in patients with rheumatoid arthritis
Cohort studyRA
Rheumatology (Oxford)9 Aug 2022
Pulmonary arterial wall thickness increased in Behçet’s disease patients with major organ involvement: Is it a sign of severity?
Cross-sectional studyVasculitis & PMR
Rheumatology (Oxford)5 Aug 2022
Risk of adverse pregnancy outcomes prior to the onset of an autoimmune rheumatic disease: a systematic review
Meta-analysisLupus & APS
Rheumatology (Oxford)5 Aug 2022
Experience with the use of mycophenolate mofetil in juvenile idiopathic inflammatory myopathies
Cohort studyMyositis
Rheumatology (Oxford)4 Aug 2022
Plasma proteomics identifies CRTAC1 as a biomarker for osteoarthritis severity and progression
Cohort studyOsteoarthritis
Rheumatology (Oxford)3 Aug 2022
Differences in symptom experience among patients with systemic sclerosis: a cluster analytic approach to identifying subgroups
Cross-sectional studySystemic sclerosis
Rheumatology (Oxford)3 Aug 2022
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis
Cross-sectional studyRA
Rheumatology (Oxford)3 Aug 2022
Clinically suspect arthralgia patients with a low educational attainment have an increased risk of developing inflammatory arthritis
Cohort studyRA
Rheumatology (Oxford)3 Aug 2022
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey
Cross-sectional studyMyositis
Rheumatology (Oxford)3 Aug 2022
Ultrasonography in the prediction of gout flares: a 12-month prospective observational study
Cohort studyGout & crystals
Rheumatology (Oxford)3 Aug 2022
Different COVID-19 outcomes among systemic rheumatic diseases: a nation-wide cohort study
Cohort studyAcross diseases
Rheumatology (Oxford)3 Aug 2022
JAK inhibitors in difficult-to-treat adult-onset Still’s disease and systemic-onset juvenile idiopathic arthritis
Cohort studyPediatric
Rheumatology (Oxford)3 Aug 2022
Effectiveness of the BNT162b2 mRNA COVID-19 vaccine among adolescents with juvenile-onset inflammatory rheumatic diseases
Cohort studyPediatric
Rheumatology (Oxford)2 Aug 2022
Utility of repeat extractable nuclear antigen antibody testing: a retrospective audit
Cohort study
Rheumatology (Oxford)29 Jul 2022
Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model
Diagnostic or prognostic studySystemic sclerosis
Rheumatology (Oxford)29 Jul 2022
Long-term follow-up of Janus-kinase inhibitor and novel active disease biomarker in juvenile dermatomyositis
Cross-sectional studyPediatric
Rheumatology (Oxford)28 Jul 2022
Prevalence of non-coeliac gluten sensitivity and assessment of the response to gluten-free diet in a cohort of patients with fibromyalgia
Cohort studyFibromyalgia & pain
Rheumatology (Oxford)27 Jul 2022
Predictors and prognostic stratification for lupus low disease activity state: results from a prospective clinical trial
Cohort studyLupus & APS

All 1,905 Briefs in ExploreShowing Briefs 1,801–1,840 of 1,905, newest first